lysophosphatidic acid has been researched along with dacarbazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dalton, JT; Li, CM; Li, W; Lu, Y; Miller, DD; Wang, Z | 1 |
| Ishimoto, K; Maeda, H; Minami, K; Otagaki, S; Tsujiuchi, T; Ueda, N | 1 |
| Ishimoto, K; Minami, K; Tsujiuchi, T; Ueda, N | 1 |
3 other study(ies) available for lysophosphatidic acid and dacarbazine
| Article | Year |
|---|---|
Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.
Topics: Amides; Animals; Antineoplastic Agents; Carboxylic Acids; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Thiazolidines; Tumor Cells, Cultured | 2010 |
Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lysophospholipids; Melanoma; Receptors, Lysophosphatidic Acid; Signal Transduction | 2019 |
Lysophosphatidic acid receptor-2 (LPA
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; Dacarbazine; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Humans; Lysophospholipids; Melanoma; Pertussis Toxin; Receptors, Lysophosphatidic Acid; Signal Transduction | 2020 |